Sexton G - Search Results

1

Verbal fluency task affects gait in Parkinson's disease with motor freezing.

Camicioli R, Oken BS, Sexton G, Kaye JA, Nutt JG. Camicioli R, et al. Among authors: sexton g. J Geriatr Psychiatry Neurol. 1998 Winter;11(4):181-5. doi: 10.1177/089198879901100403. J Geriatr Psychiatry Neurol. 1998. PMID: 10230996 Clinical Trial.

2

Determinants of tapping speed in normal control subjects and subjects with Parkinson's disease: differing effects of brief and continued practice.

Nutt JG, Lea ES, Van Houten L, Schuff RA, Sexton GJ. Nutt JG, et al. Among authors: sexton gj. Mov Disord. 2000 Sep;15(5):843-9. doi: 10.1002/1531-8257(200009)15:5<843::aid-mds1013>3.0.co;2-2. Mov Disord. 2000. PMID: 11009189

3

Evolution of the response to levodopa during the first 4 years of therapy.

Nutt JG, Carter JH, Lea ES, Sexton GJ. Nutt JG, et al. Among authors: sexton gj. Ann Neurol. 2002 Jun;51(6):686-93. doi: 10.1002/ana.10189. Ann Neurol. 2002. PMID: 12112073

4

The dopamine transporter: importance in Parkinson's disease.

Nutt JG, Carter JH, Sexton GJ. Nutt JG, et al. Among authors: sexton gj. Ann Neurol. 2004 Jun;55(6):766-73. doi: 10.1002/ana.20089. Ann Neurol. 2004. PMID: 15174010 Clinical Trial.

5

Motor slowing precedes cognitive impairment in the oldest old.

Camicioli R, Howieson D, Oken B, Sexton G, Kaye J. Camicioli R, et al. Among authors: sexton g. Neurology. 1998 May;50(5):1496-8. doi: 10.1212/wnl.50.5.1496. Neurology. 1998. PMID: 9596020 Clinical Trial.

6

Brain volume preserved in healthy elderly through the eleventh decade.

Mueller EA, Moore MM, Kerr DC, Sexton G, Camicioli RM, Howieson DB, Quinn JF, Kaye JA. Mueller EA, et al. Among authors: sexton g. Neurology. 1998 Dec;51(6):1555-62. doi: 10.1212/wnl.51.6.1555. Neurology. 1998. PMID: 9855501

7

Memory testing in dementia: how much is enough?

Derrer DS, Howieson DB, Mueller EA, Camicioli RM, Sexton G, Kaye JA. Derrer DS, et al. Among authors: sexton g. J Geriatr Psychiatry Neurol. 2001 Spring;14(1):1-6. doi: 10.1177/089198870101400102. J Geriatr Psychiatry Neurol. 2001. PMID: 11281309

8

Parkinson's disease, CYP2D6 polymorphism, and age.

Payami H, Lee N, Zareparsi S, Gonzales McNeal M, Camicioli R, Bird TD, Sexton G, Gancher S, Kaye J, Calhoun D, Swanson PD, Nutt J. Payami H, et al. Among authors: sexton g. Neurology. 2001 May 22;56(10):1363-70. doi: 10.1212/wnl.56.10.1363. Neurology. 2001. PMID: 11376189

9

Methylphenidate increases the motor effects of L-Dopa in Parkinson's disease: a pilot study.

Camicioli R, Lea E, Nutt JG, Sexton G, Oken BS. Camicioli R, et al. Among authors: sexton g. Clin Neuropharmacol. 2001 Jul-Aug;24(4):208-13. doi: 10.1097/00002826-200107000-00003. Clin Neuropharmacol. 2001. PMID: 11479391 Clinical Trial.

10

Age at onset of Parkinson disease and apolipoprotein E genotypes.

Zareparsi S, Camicioli R, Sexton G, Bird T, Swanson P, Kaye J, Nutt J, Payami H. Zareparsi S, et al. Among authors: sexton g. Am J Med Genet. 2002 Jan 15;107(2):156-61. doi: 10.1002/ajmg.10111. Am J Med Genet. 2002. PMID: 11807891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters